Tudor Investment Corp’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,866	Closed	-$4.33M	–	3275
2025 Q1	$4.77M	Buy	+40,866	New	+$4.66M	0.04%	808
2024 Q4	–	Sell	-25,832	Closed	-$2.32M	–	3034
2024 Q3	$2.32M	Buy	25,832 +6,849	+36%	+$598K	0.03%	1116
2024 Q2	$1.53M	Buy	+18,983	New	+$1.41M	0.02%	1226
2023 Q3	–	Sell	-30,321	Closed	-$2.18M	–	2296
2023 Q2	$2.18M	Buy	30,321 +6,453	+27%	+$476K	0.04%	855
2023 Q1	$1.47M	Buy	+23,868	New	+$1.57M	0.03%	966
2022 Q4	–	Sell	-20,580	Closed	-$918K	–	2391
2022 Q3	$918K	Sell	20,580 -23,282	-53%	-$1.16M	0.02%	974
2022 Q2	$1.68M	Sell	43,862 -34,105	-44%	-$1.08M	0.05%	596
2022 Q1	$3.23M	Buy	77,967 +33,693	+76%	+$1.04M	0.08%	341
2021 Q4	$1.67M	Sell	44,274 -46,055	-51%	-$1.69M	0.03%	729
2021 Q3	$2.98M	Buy	90,329 +63,668	+239%	+$2.48M	0.06%	488
2021 Q2	$1.8M	Sell	26,661 -16,667	-38%	-$1M	0.04%	612
2021 Q1	$2.45M	Buy	43,328 +38,925	+884%	+$2.74M	0.05%	431
2020 Q4	$359K	Sell	4,403 -8,978	-67%	-$671K	0.01%	1062
2020 Q3	$953K	Buy	13,381 +7,002	+110%	+$546K	0.04%	579
2020 Q2	$525K	Buy	+6,379	New	+$491K	0.03%	707
2020 Q1	–	Sell	-23,473	Closed	-$2.43M	–	1052
2019 Q4	$2.43M	Buy	+23,473	New	+$948K	0.12%	220